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Unfolded protein responseInduction of endoplasmic reticulum (ER) stress by the complement membrane attack complex is enhanced
by activation of cytosolic phospholipase A2-α (cPLA2). To address mechanisms by which cPLA2 may
modulate ER stress, we produced a mutant cPLA2, containing an ER targeting domain (cPLA2-ERmut). After
transfection and fractionation of COS-1 cells, cPLA2-ERmut was present mainly in the membrane fraction,
whereas wild type (wt) cPLA2 was principally in the cytosol. By ﬂuorescence microscopy, cPLA2-ERmut was
enriched in a perinuclear distribution under basal conditions, colocalizing with the ER protein, calnexin,
while cPLA2-wt was mainly cytosolic. Both forms of cPLA2 transiently expressed in COS cells showed basal
phosphorylation at serine505, which correlates with catalytic activity. Expression of cPLA2-wt was ∼5-fold
greater, compared with cPLA2-ERmut, but both enzymes produced comparable increases in free arachidonic
acid, implying that cPLA2-ERmut effectively hydrolyzed ER membrane phospholipids. Although transfection
of cPLA2-ERmut or wt did not induce ER stress independently, cPLA2-ERmut and wt enhanced the induction
of ER stress by tunicamycin, dithiothreitol and ionomycin (monitored by induction of grp94 and C/EBP
homologous protein-10), and the effect was dependent on the catalytic activity. cPLA2-ERmut enhanced
production of superoxide. Induction of ER stress in tunicamycin-treated cells expressing cPLA2-ERmut was
attenuated in the presence of the antioxidant, N-acetyl cysteine, and reduced glutathione, and was
exacerbated by DL-buthionine-(S,R)-sulfoximine (which depletes glutathione). Expression of cPLA2-ERmut
exacerbated tunicamycin-induced apoptosis. Thus, induction of ER stress is facilitated by the activation of
cPLA2 at the ER. The mechanism involves ER membrane phospholipid hydrolysis, and accumulation of
reactive oxygen species.idonyltriﬂuoromethyl ketone;
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Cytosolic phospholipase A2-α (cPLA2; group IVA) releases arachi-
donic acid (AA) from the sn−2 position of phospholipids [1]. cPLA2 is
found in the cytosol of many cell types, and this enzyme releases AA
for the synthesis of eicosanoids, and can contribute to cell injury [1–5].
A model of dual regulation of cPLA2 activity has been described [4,5].
Physiologic stimuli (e.g. growth factors, hormones) that raise
intracellular calcium concentration ([Ca2+]i) in the submicromolar
range, or Ca2+ ionophores may induce translocation of cPLA2 fromcytosol to an intracellular membrane, e.g. nucleus, endoplasmic
reticulum (ER) or Golgi, where cPLA2 would bind via its N-terminal
Ca2+-dependent lipid binding (CaLB) domain, gaining access to
phospholipid substrate. Second, the enzymatic activity of cPLA2 can
be increased by phosphorylation on serine505 by mitogen-activated
protein kinases. This model is relatively straightforward, and while it
appears to be valid in a number of cell types, there are exceptions, or a
requirement for additional factors [4,6]. For example, in some cells, at
least a fraction of the cPLA2 is associated with membranes at resting
[Ca2+]i [7,8]. There is also evidence supporting the role of other
regions of cPLA2 (including the catalytic domain) in membrane
binding, although the catalytic domain probably does not bind to
membrane lipids in the absence of the CaLB domain, but rather,
strengthens the association of the enzyme with the membrane [9,10].
Inositol phospholipids, ceramide, and cytoskeletal proteins appear to
be involved in the activation of cPLA2 in certain cells [8,11–14].
Secretory, lumenal and membrane proteins are glycosylated and
attain their correctly folded conformation in the ER via ER-resident
enzymes and chaperones [15]. Folding-competent states are main-
tained by classical chaperones, e.g. the glucose-regulated proteins
(grp)94 and bip (grp78), lectin-like chaperones, e.g. calnexin,
calreticulin, and oxidoreductases/isomerases. To rescue misfolded
proteins, the ER has in place quality control machinery, including the
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response that upregulates the capacity of the ER to process abnormal
proteins. Upon accumulation of misfolded proteins in the ER,
activating transcription factor-6 moves to the Golgi, and is cleaved
by proteases. The cleaved cytosolic fragment migrates to the nucleus
to activate transcription of chaperones. In parallel, inositol requiring-
1α (IRE1α) activates its endoribonuclease activity, cleaving X-box
binding protein-1 mRNA and changing the reading frame to yield a
potent transcriptional activator. Normally, ER stress proteins serve as
protein chaperones for exocytosis from the ER, and may complex
with defective proteins to target them for degradation. During stress,
the induction of ER chaperones may limit accumulation of abnormal
proteins. Another aspect of the UPR involves PERK (PKR-like ER
kinase), which is activated to phosphorylate the eukaryotic transla-
tion initiation factor-2α subunit (eIF2α). This process reduces
initiation AUG codon recognition; thus, the general rate of translation
is reduced (which decreases the protein load on a damaged ER). The
UPR may allow cells to recover from stress, and may be protective to
additional insults, but substantial/prolonged ER stress may lead to
apoptosis, in part, via induction of speciﬁc genes, e.g. CHOP (C/EBP
homologous protein-10; also known as GADD153) [19,21,22].
In previous studies, we demonstrated that activation of cPLA2 can
enhance the UPR [23,24]. Using an experimental model of membra-
nous glomerulonephritis (in vivo and in cell culture), we showed
that the complement C5b-9 membrane attack complex is assembled
in glomerular epithelial cells, where it induces cell injury in associa-
tion with the activation of cPLA2, release of AA, and production of
prostanoids [25]. In parallel, assembly of C5b-9 induced ER stress,
speciﬁcally, an increase in ER chaperones, including bip and grp94,
activation of PERK, phosphorylation of eIF2α and a reduction in
translation. Overexpression of cPLA2 facilitated the activation of the
ER stress response by C5b-9 possibly by inducing damage to the
membrane of the ER. Conversely, the C5b-9-mediated induction of the
UPR was attenuated when cPLA2 was inhibited. cPLA2 activation
exacerbated C5b-9-induced glomerular epithelial cell injury, whereas
induction of the UPR was cytoprotective [23,24].
In this study, we address the mechanisms by which cPLA2 may
enhance ER stress. We expressed a mutant cPLA2, which was targeted
to the ER (cPLA2-ERmut). cPLA2-ERmut and the wild type (wt)
enzyme were phosphorylated at serine505 and hydrolyzed phospho-
lipids to release AA. Expression of cPLA2-ERmut and wt enhanced the
induction of ER stress by ionomycin, tunicamycin, and dithiothreitol.
The mechanism involves ER membrane phospholipid hydrolysis, and
production and accumulation of reactive oxygen species.
2. Materials and methods
2.1. Materials and plasmid construction
Tissue culture reagents and Lipofectamine 2000were obtained from
Invitrogen (Burlington,Ontario). Ionomycin, tunicamycin, dithiothreitol
(DTT), AA, N-acetyl-cysteine (NAC), glutathione (GSH), DL-buthionine-
(S,R)-sulfoximine (BSO), indomethacin, arachidonyltriﬂuoromethyl
ketone (AACOCF3), and fura-2-acetoxymethyl ester were obtained
from Sigma-Aldrich Canada (Mississauga, Ontario). Bisbenzimide
H33342 ﬂuorochrome, and propidium iodide were obtained from
Calbiochem (La Jolla, California). [3H]AA (100 mCi/mmol) was pur-
chased from Perkin-Elmer Life & Products (Boston, MA). Redivue
Pro Mix [35S]methionine/cysteine (1000 Ci/mmol) was from Amer-
sham Biosciences (Baie d'Urfé, QC). Electrophoresis and immunoblot-
ting reagents were from Jackson ImmunoResearch (West Grove,
Pennsylvania), Pall Corporation (Pensacola, Florida), and GE Healthcare
(Baie d'Urfé, Quebec). Rabbit anti-calnexin, and rat anti-grp94 anti-
bodies were from Assay Designs (Ann Arbor, Michigan). Mouse anti-
green ﬂuorescent protein (GFP) and rabbit anti-CHOP antibodies were
from Santa Cruz Biotechnology (Santa Cruz, California). Rabbit anti-phospho-cPLA2 serine505, and rabbit anti-phospho-c-Jun N-terminal
kinase (JNK) threonine183/tyrosine185 antibody were purchased from
Cell Signaling Technology (Danvers, MA). Rabbit antiserum to human
recombinant cPLA2 was kindly provided by Dr. Z. Huang (Merck-Frosst
Canada, Pointe Claire-Dorval, QC). Human wt cPLA2 cDNA subcloned in
vector pMT2 was described previously [10]. The cDNA encoding a
chimeric protein containingGFP at the carboxyl terminus of cPLA2 (GFP-
cPLA2) in vector pEGFP-N3 (BD Biosciences, Mississauga, ON) was
kindly provided by Dr. T. Hirabayashi (University of Tokyo, Tokyo,
Japan) [6].
cPLA2-ERmut contains a 28 amino acid ER targeting sequence from
cytochrome b5 [26,27] fused to the catalytic domain of cPLA2 (amino
acids 131–749). In this construct, the cPLA2 CaLB domain has been
deleted. To produce cDNA encoding the ER targeting sequence, rabbit
cytochrome b5 cDNA (kindly provided by Dr. G. Shore, McGill
University) was ampliﬁed by the polymerase chain reaction using the
forward primer 5′-AAACTGCAGCGGCCGCCATGTCCAGCTGGTGGAC-
CAAC-3′ and reverse primer 5′-CTAGTCTAGAACGTCGTCGGCCATGTA-
GAG-3′. AnER targeting sequence for the catalytic domainofGFP-cPLA2-
ERmut was produced in an analogous manner, except that the forward
PCR primer was 5′-GGAAGATCTACCATGTCCAGCTGGTGGACCAAC-3′.
All primers include appropriate ﬂanking restriction enzyme sites to
facilitate subcloning. Construction of cPLA2-CaLB (amino acids 1–178)
was published previously [8].
2.2. Cell culture, transfection and fractionation
COS-1 cells and Madin–Darby canine kidney (MDCK) cells were
grown on plastic substratum in DMEM with 10% fetal calf serum [24].
Culture of rat glomerular epithelial cells was detailed previously
[10,28]. COS cells and glomerular epithelial cells were transiently
transfected with plasmid DNAs using the Lipofectamine 2000 reagent,
according to the manufacturer's instructions.
For fractionation, COS cells were collected in homogenization buffer
containing 50 mM Hepes, 0.25 M sucrose, 1 mM EDTA, 1 mM EGTA,
20 μM leupeptin, 20 μM pepstatin, 0.1 mM PMSF, pH 7.4 [7,10].
Following centrifugation for 3 min at 1500×g, the pellet was homog-
enized with 25 strokes in a Wheaton homogenizer, centrifuged for
5 min at 2500×g, and the supernatant was collected. The remaining
pellet was again homogenized and centrifuged for 5 min with the
supernatant being pooled with that collected earlier. The supernatant
was centrifuged at 100,000×g for 60 min to prepare membrane and
cytosolic fractions [7,10]. Alternatively, the supernatant was ﬁrst
centrifuged at 8000×g for 10 min, followed by 50,000×g for 2 h.
2.3. Radiolabeling with [3H]AA and lipid separation
Phospholipids were radiolabeled to isotopic equilibrium by incu-
bating COS cells with [3H]AA (0.125 μCi/ml) for 48–72 h [10,29,30]. At
the end of incubations, supernatants and cells were collected, lipids
were extracted with chloroform:methanol (1:1.2) and 0.2% formic
acid, followed by chloroform, and were then dried under nitrogen.
After reconstitution in chloroform:methanol (2:1) and addition
of “cold” AA standard, the free AA was separated from other lipids
by thin layer chromatography in hexane:diethyl ether:acetic acid
(80:20:2). Relevant bands were scraped and radioactivity was quan-
tiﬁed in a β liquid scintillation counter [10,29,30].
2.4. Immunoprecipitation of calnexin-associated proteins
COS cells were radiolabelled with [35S]methionine/cysteine
(50 µCi/ml) in methionine/cysteine-free DMEM for 24 h. After
washing, cells were chased in DMEM replete with “cold” methionine/
cysteine, for 20–180 min, in the presence or absence of ionomycin
(1 µM). Then, cells were lysed and immunoprecipitated with anti-
calnexin antiserum. Immune complexes were incubated with agarose-
470 G. Ren et al. / Biochimica et Biophysica Acta 1803 (2010) 468–481coupled protein A. Complexes were boiled in Laemmli sample buffer,
and subjected to SDS-PAGE and ﬂuorography [31].2.5. Immunoblotting
Following cell lysis, samples were adjusted to contain equal
amounts of proteins, which were loaded into each lane of a gel. After
SDS-PAGE, proteins were electrophoretically transferred onto nitro-
cellulose paper, blocked with 5% milk, and incubated with primary
antibody, and then with horseradish peroxidase-conjugated second-
ary antibody. The blots were developed using the enhanced chemi-
luminescence technique (ECL). Protein content was quantiﬁed by
scanning densitometry, using NIH ImageJ software [23,24]. Prelimi-
nary studies demonstrated that there was a linear relationship
between densitometric measurements and the amounts of protein
loaded onto gels.2.6. Immunoﬂuorescence microscopy
After transfection and incubation, cells adherent to coverslips were
ﬁxed with 3% paraformaldehyde in PBS (30 min), and were stained
with rabbit anti-calnexin antibody and rhodamine-conjugated anti-
rabbit IgG, as described previously [7]. Coverslips were inverted,
mounted onto glass slides, and examined with a Zeiss AxioObserver
ﬂuorescence microscope with visual output connected to an AxioCam
digital camera. Images were collected from series of images derived
from different focal planes (Z-stack). Merging of ﬂuorescence images
was carried out with Adobe Photoshop software.Fig. 1. Cellular localization of cPLA2. After transient transfection of COS cells with cDNAs, ce
cPLA2-wt proteins (B) were found in the cytosolic fraction, and to a lesser extent in the me
mainly in the membrane fraction. Endogenous cPLA2-wt is not readily detected at this expo
likely represent degradation products (A). Calnexin is a marker of the ER (microsomes; B). C
were transiently transfected with GFP-cPLA2-wt or GFP-cPLA2-ERmut cDNAs. After 48 h,
secondary antibody, as well as Hoechst H33342 to identify nuclei. Cells were visualized by2.7. Measurement of superoxide anion production
Superoxide anion production was measured as described previ-
ously [32,33]. Cells were washed, scraped in homogenization buffer,
and pelleted by centrifugation at 200×g for 5 min at 4 °C. The pellet
was resuspended in assay buffer, containing 130 mM NaCl, 5 mM KCl,
1 mM MgCl2, 35 mM sodium phosphate, and 20 mM Hepes (4 °C).
Cells were counted in a hemacytometer and were then centrifuged
again at 200×g for 5 min at 4 °C, and resuspended in assay buffer. The
measurement of superoxide generation was carried out in a Berthold-
Lumat LB 9507 luminometer. To start the assay, luciginin (ﬁnal
concentration 250 µM) was added to 1×106 cells in a total volume of
1 ml of assay buffer. Luciginin exhibits chemiluminescence that is
sensitive to the superoxide anion. Photoemission in terms of relative
light units (RLU) was measured every 5 s for 200 s. A buffer blank was
subtracted from each reading.2.8. Measurement of ER Ca2+ content
The method has been described in detail [29]. Brieﬂy, COS cells
were loaded in suspension with 5 µM fura-2-acetoxymethyl ester in
buffer containing 0.5 mM CaCl2 for 30 min at 37 °C. After washing,
aliquots of cells were placed into a spectroﬂuorometer in Ca2+-free
buffer, containing 2 mM EGTA. Fluorescence of fura-2 was monitored
continuously (emission wavelength of 510 nm, excitation wave-
lengths alternating between 340 and 380 nm) at 37 °C. Release of
Ca2+ from intracellular storage sites (ER)was initiated by the addition
of 5 µM ionomycin, and fura-2 ﬂuorescence was monitored for a
further 10 min.lls were fractionated and subjected to immunoblotting. Ectopic cPLA2-wt (A) and GFP-
mbrane fraction. cPLA2-ERmut (A) and GFP-cPLA2-ERmut proteins (B) were recovered
sure (A). Bands of lower molecular mass visible in cells expressing ectopic cPLA2s most
: Densitometric quantiﬁcation (C, cytosol, M, membrane). D: Glomerular epithelial cells
cells were stained with anti-calnexin antibody, followed by a rhodamine-conjugated
ﬂuorescence microscopy. Untr, untreated; Iono, ionomycin (10 µM, 10 min).
Fig. 1 (continued).
471G. Ren et al. / Biochimica et Biophysica Acta 1803 (2010) 468–4812.9. Hoechst H33342 and propidium iodide staining
Nuclear staining with Hoechst H33342 dye was used to quantify
apoptosis, as described previously [34]. Brieﬂy, adherent cells were
stained with H33342 (1 µg/ml) for 10 min at 37 °C without ﬁxation.
After washing with PBS, cells were stained with propidium iodide
(5 µg/ml) to identify necrotic or late apoptotic cells. Cells were
examined using a Zeiss AxioObserver ﬂuorescence microscope, and
the number of H33342- and propidium iodide-positive cells was
quantiﬁed by visual counting. H33342-positive cells (i.e. with
condensed and/or fragmented nuclei) without propidium iodide
staining were deﬁned as apoptotic. Propidium iodide-positive cells
were deﬁned as late apoptotic [34].
2.10. Statistics
Data are presented as mean±SEM. The t statistic was used to
determine signiﬁcant differences between two groups. One-way
ANOVA was used to determine signiﬁcant differences among groups.
Where signiﬁcant differences were found, individual comparisons
were made between groups using the t statistic, and adjusting the
critical value according to the Bonferroni method.
3. Results
3.1. Cellular localization and characterization of cPLA2-ERmut
Previously, we showed that activation of cPLA2 by complement
C5b-9 in glomerular epithelial cells perturbed the ER and ampliﬁedthe induction of ER stress [23]. To study the interaction of cPLA2 with
the membrane compartment, earlier we produced a membrane
targeted mutant form of cPLA2 [10]. By analogy, to better understand
the mechanisms by which cPLA2 may enhance ER stress, in this study,
we produced a cDNA construct in which we deleted the CaLB domain
of wt cPLA2, and fused the catalytic domain of cPLA2 or GFP-tagged
cPLA2 with the ER targeting domain of cytochrome b5 (cPLA2-ERmut).
We employed COS-1 cells for most experiments, since these cells
express a low level of endogenous cPLA2 [8,30], thereby allowing us to
test the effects of cPLA2-ERmut or wt, using transient overexpression.
Following transient transfection, resting COS cells were fractionated
in Ca2+-free buffer. After separation of post-nuclear supernatants into
cytosolic and membrane fractions, ectopic cPLA2-wt and GFP-cPLA2-wt
proteins were found mainly in the cytosolic fraction (Fig. 1A–C).
However, a smaller portion of cPLA2-wt appeared together with the
ER membrane protein, calnexin, in the membrane fraction (Fig. 1A–
C), in keeping with our earlier observations [7,8,10], and indicating
that a small fraction of cPLA2-wt was pre-associated with the
membrane compartment even in resting cells. In contrast, cPLA2-
ERmut and GFP-cPLA2-ERmut proteins were recovered mainly in the
membrane fraction together with calnexin (Fig. 1A–C). Localization
of GFP-cPLA2 was also studied by immunoﬂuorescence microscopy
in glomerular epithelial cells. The distribution of GFP-cPLA2-wt
protein was mainly cytosolic, and there was minimal colocalization
with calnexin (Fig. 1D). Incubation of the cells with a high dose of the
Ca2+ ionophore, ionomycin, induced some translocation to the
perinuclear region and increased colocalization with calnexin
(Fig. 1D). Since membranes of the ER and nucleus are contiguous,
perinuclear accumulation of GFP-cPLA2-wt and colocalization with
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These results are in keeping with our previous study, which reported
a cytosolic localization for cPLA2-wt (i.e. without the GFP tag) in
resting cells, shifting to the perinuclear membrane after treatment
with a high dose of Ca2+ ionophore [7]. In contrast, GFP-cPLA2-
ERmut was enriched in a perinuclear distribution under basal con-
ditions and colocalized with calnexin (Fig. 1D). Together with the
localization of cPLA2-ERmut in the membrane fraction, the results
imply that cPLA2-ERmut is concentrated at the ER.
Phosphorylation of cPLA2 at serine505 correlates with catalytic
activity. By immunoblotting with anti-cPLA2 phosphoserine505 anti-
body, we demonstrate that wt and mutant forms of cPLA2 transiently
expressed in COS cells show basal phosphorylation at serine505
(Fig. 2A and B). Endogenous cPLA2-wt protein could be detected in
COS cells (particularly when blots were overexposed), and was
phosphorylated at serine505 weakly and inconsistently (Fig. 2A).
Expression of cPLA2-ERmut in COS cells was generally at a level
comparable to endogenous cPLA2-wt (Fig. 2A), whereas ectopic
cPLA2-wt protein was substantially overexpressed, and its level was
consistently greater, as compared with cPLA2-ERmut (Fig. 2A and C).
Compared with cPLA2-wt, the synthesis of cPLA2-ERmut may haveFig. 2. Characterization of cPLA2-wt and ERmut. A–C: COS cells were transfected with un
immunoblotted with antibodies to cPLA2 or cPLA2 phosphoserine505. All forms of cPLA2 trans
of ectopic cPLA2-wt protein was signiﬁcantly greater, as compared with cPLA2-ERmut (A an
protein is detected in the cPLA2-ERmut transfection (A), and weak phosphorylation of seri
transfected cells is probably a degradation product. There is a non-speciﬁc bandmigrating be
in COS cells transfected with cPLA2-wt (+) or vector (−), and in untransfected MDCK cells. C
E: COS cell phospholipids were labeled with [3H]AA. Transfection of COS cells with GFP-cPLA2
*pb0.05 vs control (Ctrl), 4 experiments. F: COS cells were labeled with [3H]AA, and were th
the 8000×g pellet of the centrifuged post-nuclear supernatant (Materials and methods), frac
is the cytosol. The [3H]AA and calnexin content of each fraction were measured.been reduced or degradation may have been greater. Nevertheless, it
should be noted that while the level of ectopic cPLA2-wt in transfected
COS cells is high, this level is comparable to the amount of endogenous
cPLA2-wt in MDCK cells (Fig. 2D), suggesting that the amount of
cPLA2-wt overexpression in COS cells is within a physiological range.
To verify that cPLA2-ERmut is able to hydrolyze phospholipids, COS
cell phospholipids were labeled with [3H]AA. Transfection of COS cells
with GFP-cPLA2-wt and GFP-cPLA2-ERmut resulted in ∼30% increases
in free [3H]AA levels (Fig. 2E). Similar results were obtained after
transfection of COS cells with cPLA2-wt and cPLA2-ERmut (i.e. without
the GFP tag; data not shown). In experiments involving transfection of
cPLA2-ERmut, cells were also treated with the cPLA2-directed
inhibitor, AACOCF3 (25 µM) for 24 h [35]. Compared with untreated
cells, AACOCF3 reduced free [3H]AA by 98±3% (3 experiments).
AACOCF3 did not, however, reduce free [3H]AA in vector-transfected
cells, indicating that this inhibitor blocked [3H]AA release stimulated
by the cPLA2-ERmut, but that basal [3H]AA was independent of cPLA2.
Thus, transfected wt and mutant cPLA2s are both functionally active.
Since expression of the mutant was substantially lower, compared
with the wt, the results suggest that the mutant may be signiﬁcantly
more active than the wt. Alternatively, the majority of cPLA2-wt wastagged (A) or GFP-tagged cPLA2-wt and cPLA2-ERmut cDNAs (B), and lysates were
iently overexpressed in COS cells showed basal phosphorylation at serine505. Expression
d C). C: Densitometric quantiﬁcation; *pb0.0001, 3 experiments. Endogenous cPLA2-wt
ne505 is also detectable on this blot. The lower molecular mass band in the cPLA2-wt-
tween GFP-cPLA2-wt and GFP-cPLA2-ERmut (B, upper panel). D: Expression of cPLA2-wt
ell lysates were immunoblotted with anti-cPLA2 antibody. Loading— amido black stain.
-wt and GFP-cPLA2-ERmut resulted in increases in free [3H]AA (48 h after transfection).
en subjected to fractionation. Fraction 1 contains nuclei and unbroken cells, fraction 2 is
tion 3 is the 50,000×g pellet of the centrifuged post-nuclear supernatant, and fraction 4
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interacting with lipid substrate within membranes. Finally, we
veriﬁed that the [3H]AA-labeled lipids were actually found in cell
fractions that contained calnexin (Fig. 2F). Although this result
does not speciﬁcally show that ER phospholipids are the source of
released [3H]AA, the result is in keeping with our earlier study, which
demonstrated directly that cPLA2 released [3H]AA from ER phospho-
lipids [7].3.2. Expression of cPLA2-ERmut and cPLA2-wt facilitates induction of ER
stress
In the next series of experiments we assessed if expression of
cPLA2 leads to the induction of ER stress. One aspect of the UPR is the
upregulation of ER chaperones, including grp94, secondary to the
activation of activating transcription factor-6. In preliminary studies,
we observed that transfection of cPLA2-wt and cPLA2-ERmut in COS
cells did not independently affect the level of grp94 (result not
shown). Tunicamycin, a drug that blocks N-linked glycosylation and
causes an accumulation of misfolded proteins in the ER, is an inducer
of ER stress, and incubation of COS cells with tunicamycin resulted in a
modest increase in grp94 (Fig. 3). Transfection of cPLA2-wt and, in
particular, cPLA2-ERmut enhanced the induction of grp94 signiﬁcantly
after 6 h incubation with tunicamycin (Fig. 3). After 24 h, tunicamycinFig. 3. Expression of cPLA2-ERmut and cPLA2-wt facilitates induction of grp94. COS cells
Tunicamycin (Tunic; 10 µg/ml) was added after 48 h, and the cells were further incubated f
non-speciﬁc band — loading control. A: Representative immunoblot; B, densitometric quant
control-Tunic and pb0.006 cPLA2-ERmut vs wt-Tunic, +pb0.01 control-Tunic vs control-unstimulated a large increase in grp94 expression, such that there was
no additional effect of cPLA2-wt or cPLA2-ERmut (Fig. 3).
A second aspect of the UPR involves activation of PERK and
phosphorylation of eIF2α. This phosphorylation is associated with a
global decrease in translation, but certain mRNAs may be translated
preferentially. Among these is activating transcription factor-4, which
induces expression of several genes, including CHOP, a gene closely
associated with apoptosis and/or growth arrest [21]. First, we
conﬁrmed that similarly to grp94, transfection of wt or mutant
cPLA2 did not induce CHOP expression in unstimulated cells (e.g. in
the absence of tunicamycin; Fig. 4A). By analogy to grp94, transfection
of cPLA2-wt, and particularly cPLA2-ERmut enhanced the expression
of CHOP after induction of ER protein misfolding with tunicamycin
(Fig. 4B–D). The enhancement of CHOP expressionwas delayed (24 h;
Fig. 4C and D), compared with grp94 (6 h). Tunicamycin induced a
small and inconsistent increase in CHOP after 6 h of incubation, and
there was no apparent enhancement of CHOP by cPLA2-wt and cPLA2-
ERmut at this time point (Fig. 4B). In some experiments, cells were
treatedwith the cPLA2-directed inhibitor, AACOCF3 (50–100 µM) [35],
concurrent with the transfection and incubation with tunicamycin
(24 h). The effect of cPLA2-ERmut on the enhancement of CHOP
expressionwas blocked by 100 µMAACOCF3 (Fig. 4E). The same result
was observed with 50 µM AACOCF3 (i.e. tunicamycin-induced CHOP
expression was not enhanced in the presence of cPLA2-ERmut+
AACOCF3), implying that the effect of cPLA2-ERmut involves cPLA2were transiently transfected with cPLA2-wt and cPLA2-ERmut cDNAs, as indicated.
or 6 or 24 h. Lysates were immunoblotted with anti-grp94 or anti-cPLA2 antibodies. NS,
iﬁcation of grp94. B: *pb0.035 cPLA2-wt vs control-Tunic, **pb0.0001 cPLA2-ERmut vs
treated, 2 duplicate experiments.
Fig. 4. Expression of cPLA2-ERmut and cPLA2-wt facilitates induction of CHOP. COS cells were transiently transfected with cPLA2-wt and cPLA2-ERmut cDNAs, as indicated. Lysates
were immunoblotted with anti-CHOP or anti-cPLA2 antibodies. A: Unstimulated cells. B–E: Tunicamycin (10 µg/ml) was added after 48 h, and the cells were further incubated for 6 h
(B), or 24 h (C–E). In some experiments (E), cells were treated with AACOCF3 (100 µM) concurrent with the transfection. Expression of cPLA2-ERmut signiﬁcantly enhanced CHOP
induction by tunicamycin. B and C: Representative immunoblots; D and E, densitometric quantiﬁcation of CHOP. D: *pb0.05 cPLA2-wt vs control-Tunic, **pb0.0001 cPLA2-ERmut vs
all groups, 4 experiments. E: There is no signiﬁcant difference between column 1 and 2, *pb0.001 vs control. F and G: COS cells transfected with cPLA2-wt and cPLA2-ERmut cDNAs
were incubated with DTT (2 mM) for 6 h. G: Densitometric quantiﬁcation, *pb0.01 cPLA2-ERmut and cPLA2-wt vs control, 4 experiments.
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and intermolecular disulﬁde bonds from forming between cysteine
residues of proteins, thereby inducing ER protein misfolding and ER
stress. By analogy to tunicamycin, transfection of COS cells with
cPLA2-ERmut enhanced the induction of CHOP after incubation with
DTT (Fig. 4F and G). Expression of cPLA2-wt also led to an increase in
CHOP. It should be noted that tunicamycin and DTT did not affectthe level of free [3H]AA in COS cells transfected with cPLA2 (data not
shown).
ER stress has also been reported to occur after treatment of cells
with Ca2+ ionophores [23]. In an earlier study, we showed that
ionomycin stimulated increases in ER chaperones in glomerular
epithelial cells, and that the effect of ionomycin was more prominent
in glomerular epithelial cells that stably overexpress cPLA2-wt [23].
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and then stimulated the cells with or without ionomycin for 6 h.
Addition of ionomycin to cPLA2-wt-transfected cells increased grp94
expression by 36% (p=0.04, 4 experiments), while there was no
signiﬁcant increase in vector-transfected cells. Next, we transiently
transfected COS cells with cPLA2-wt and cPLA2-ERmut, and then
incubated cells with or without ionomycin. After 6 h, grp94
expression was greatest in cells transfected with cPLA2-ERmut and
treated with ionomycin (Fig. 5A and C). At 24 h, grp94 expression
increased further in the ionomycin-treated cells, but there were no
apparent differences between transfected and control cells (Fig. 5A
and C). In addition, at 24 h, expression of cPLA2-ERmut signiﬁcantly
enhanced the induction of CHOP by ionomycin. The increase in CHOP
after transfection of cPLA2-wt and stimulation with ionomycin did
not, however, reach statistical signiﬁcance.
Since ionomycin can potentially induce distinct effects in cells, we
assessed if the increases in grp94 and CHOP (Fig. 5) were actually
associated with perturbed protein folding in the ER. Wemonitored forFig. 5. Expression of cPLA2-ERmut facilitates induction of grp94 and CHOP by ionomycin. COS
Ionomycin (Iono, 1 µM; A) was added after 48 h, and the cells were further incubated for
antibodies. C and D: Densitometric quantiﬁcation. C: *pb0.015 cPLA2-ERmut vs control (Ionthis effect of ionomycin by examining association of proteins with
calnexin [31]. COS cells were metabolically labeled with [35S]
methionine+cysteine, and were then chased in medium replete
with “cold” methionine and cysteine in the presence or absence of
ionomycin. Cells were then lysed and immunoprecipitated with anti-
calnexin antibody at serial intervals, and examined by ﬂuorography.
In this assay 35S-labeled bands represent calnexin-associated proteins,
which are typically the incompletely folded or misfolded glycopro-
teins in the ER. The amount of calnexin-associated proteins was
increased in the presence of ionomycin at 20–180 min of chasing,
indicating an ionomycin-induced defect in ER protein folding capacity
(Fig. 6), which may contribute to the induction of the UPR.
The above experiments showed that in the presence of tunicamy-
cin, DTT, or ionomycin, expression of cPLA2-ERmut, and generally
cPLA2-wt enhanced induction of ER stress. Also, enhancement of ER
stress was dependent on cPLA2 enzymatic activity (i.e. presence of
the catalytic domain). cPLA2-wt associates with intracellular mem-
branes via its CaLB domain (cPLA2-CaLB). To verify that ER stresscells were transiently transfected with cPLA2-wt and cPLA2-ERmut cDNAs, as indicated.
6 or 24 h (A), or 24 h (B). Lysates were immunoblotted with anti-grp94 or anti-CHOP
o, 6 h), 4 experiments. D: *pb0.0001 cPLA2-ERmut vs control (Iono), 4 experiments.
Fig. 6. Ionomycin increases association of proteins with calnexin. COS cells were
incubated in methionine and cysteine-free culture medium supplemented with [35S]
methionine+cysteine for 24 h. Cells were then chased in medium replete with “cold”
methionine and cysteine in the presence or absence of ionomycin (Iono; 1 µM) for 20 or
40 min (3 experiments), and 90 or 180 min (2 experiments). Cells were lysed and
immunoprecipitated with anti-calnexin antibody. Immunoprecipitates were subjected
to SDS-PAGE and ﬂuorography (A). B: Densitometric quantiﬁcation, *pb0.035, **pb0.02
ionomycin vs control.
Fig. 7. ER stress is not affected by the expression of the cPLA2 CaLB domain (cPLA2-
CaLB). COS cells were transfected with cPLA2-CaLB, cPLA2-wt, and cPLA2-ERmut cDNAs,
as indicated, and were incubated with tunicamycin (as in Fig. 4). Lysates were
immunoblotted with anti-cPLA2 or anti-CHOP antibodies. B: Densitometric quantiﬁca-
tion, *pb0.03 wt vs control (tunicamycin), **pb0.015 ERmut vs control (tunicamycin),
4 experiments.
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associating with the ER membrane, we examined if expression of
cPLA2-CaLB could enhance ER stress. COS cells were transfected with
cPLA2-CaLB, and for comparison, with cPLA2-wt, and cPLA2-ERmut.
Then, cells were incubated with tunicamycin. The CaLB domain was
highly expressed in the cells (Fig. 7); however, cPLA2-CALB did not
further enhance tunicamycin-induced CHOP expression, whereas
cPLA2-ERmut and wt enhanced induction of CHOP (Fig. 7).
A third aspect of the UPR involves activation of IRE1α, which may
then lead to recruitment and activation of apoptosis signal-regulating
kinase 1, followed by activation of JNK. After transfection of COS cells
with cPLA2-ERmut, and incubation with or without tunicamycin, JNK
phosphorylation (which reﬂects activation) was monitored by
immunoblotting with phospho-speciﬁc antibody. In contrast to
grp94 and CHOP, tunicamycin appeared to reduce phosphorylation
of JNK isoforms, and there were no signiﬁcant effects of cPLA2-ERmut
(Fig. 8), suggesting that there is no signiﬁcant activation of the IRE1α-
JNK pathway in this model.
3.3. Mechanisms of ER stress enhancement by cPLA2-ERmut
In the next series of experiments, we employed cPLA2-ERmut to
address the mechanisms by which cPLA2 could enhance ER stress.
First, we addressed a potential role of oxidative stress in exacerbating
ER stress. COS cells were transiently transfected with cPLA2-ERmut
and incubated with tunicamycin. The increase in CHOP expression in
the cells transfected with cPLA2-ERmut was attenuated in thepresence of NAC or GSH, reducing agents that enhance the cellular
GSH pool and are antioxidants (Fig. 9A and C). However, NAC and GSH
did not reduce CHOP expression in vector-transfected cells that had
been treated with tunicamycin (Fig. 9B). BSO is a compound that
depletes GSH by inhibiting γ-glutamylcysteine synthetase, the
enzyme responsible for the rate limiting step of GSH synthesis [36],
and a reduction in cellular GSH levels may also result in accumulation
of reactive oxygen species (ROS). The increase in CHOP expression
induced by cPLA2-ERmut and tunicamycin was further enhanced in
the presence of BSO (Fig. 9D and E). It should also be noted that CHOP
expression was not induced by exposure of COS cells to H2O2 (Fig. 9F).
Thus, the effect of an exogenous oxidant was distinct from the effect of
cPLA2-ERmut.
3.4. Expression of cPLA2-ERmut increases production of superoxide anion
The above experiments support the view that in the context of
cPLA2-ERmut expression, oxidative stress may exacerbate ER stress. In
the next experiments, we monitored the generation of superoxide
anion after expression of cPLA2-ERmut. COS cells produced superox-
ide anion in a time-dependent manner, and there was signiﬁcantly
greater superoxide anion production after transfection of cPLA2-
ERmut, compared with control (Fig. 10A and B). Superoxide
production after transfection of cPLA2-wt tended to be greater, as
Fig. 8. Expression of cPLA2-ERmut does not affect JNK phosphorylation (pJNK). COS cells were transfected with cPLA2-ERmut, as indicated, and were incubated with or without
tunicamycin (as in Fig. 4). For comparison, COS cells were exposed to UV radiation for 2 min, and were harvested after 90 min. JNK phosphorylation was monitored by
immunoblotting with phospho-speciﬁc antibody.
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signiﬁcance (Fig. 10B). Interestingly, we did not detect ROS produc-
tion after incubation of COS cells with tunicamycin (Fig. 10C).
3.5. Expression of cPLA2-ERmut does not affect ER Ca
2+
Another potential mechanism by which cPLA2-ERmut could
enhance ER stress is by altering ER Ca2+ stores. To investigate this
mechanism, COS cells that were transiently transfected with vector,
cPLA2-wt or cPLA2-ERmut cDNAs were loaded with the Ca2+
indicator, fura-2 AM, and were then incubated with or without
ionomycin in Ca2+-free buffer. Under these experimental conditions,
the increase in [Ca2+]i following ionomycin treatment reﬂects the
amount of Ca2+ in the ER. There were no signiﬁcant differences
among the control, cPLA2-wt and cPLA2-ERmut groups (Fig. 10D).
3.6. Expression of cPLA2-ERmut enhances induction of apoptosis
CHOP is a proapoptotic gene, and since CHOP expression increased
after treatment of cPLA2-ERmut-transfected COS cells with agonists
including tunicamycin, we examined if induction of CHOP was
associated with apoptosis. COS cells were transiently transfected
with cPLA2-wt or cPLA2-ERmut, and were incubated with or without
tunicamycin for 72 h. There were no signiﬁcant differences in
apoptosis in the absence of tunicamycin (Fig. 11), suggesting that
overexpression of cPLA2-wt or cPLA2-ERmut was not independently
cytotoxic (Fig. 11). However, in the presence of tunicamycin,
expression of cPLA2-ERmut exacerbated apoptosis signiﬁcantly,
compared with tunicamycin alone (Fig. 11). Expression of cPLA2-wt
tended to increase tunicamycin-induced apoptosis, but the change
was not statistically signiﬁcant (Fig. 11).
4. Discussion
Previously, we demonstrated that induction of ER stress after
assembly of complement C5b-9 was enhanced by the activation of
cPLA2-wt [23,24]. Speciﬁcally, induction of ER chaperones by C5b-9
was ampliﬁed when cPLA2-wt was overexpressed, and conversely,
reduced when cPLA2-wt was inhibited. In resting cells, cPLA2-wt is
localized primarily in the cytosol, although a fraction may be
associated with the membrane compartment [7,8]. Following activa-
tion of cells, a portion of cPLA2-wt may translocate from the cytosol to
the membrane compartment, including the nuclear membrane, ER,
Golgi and plasma membrane [4,5]. In the present study, we expressed
an ER-targeted form of cPLA2 (cPLA2-ERmut) to facilitate the
elucidation of mechanisms by which cPLA2 can exacerbate ER stress.
cPLA2-ERmut was found mainly in the membrane fraction, and had a
perinuclear distribution in cells, colocalizing with calnexin, consistent
with localization at the ER (Fig. 1). Constitutive phosphorylation at
serine505 (which correlates with catalytic activity) was detectable in
resting cells, and the mutant enzyme was able to hydrolyze [3H]AA-labeled phospholipids to release free [3H]AA (Fig. 2). Induction of ER
stress was monitored by measuring changes in the expression of
grp94, which primarily reﬂect activation of the activating transcrip-
tion factor-6 pathway (and to some extent IRE1α), and changes in the
level of CHOP, reﬂecting activation of the PERK pathway [16,17].
While expression of cPLA2-ERmut did not independently induce
increases in the expression of grp94 or CHOP, cPLA2-ERmut sig-
niﬁcantly exacerbated induction of grp94 and CHOP in cells treated
with compounds that can induce ER stress, including tunicamycin,
ionomycin and DTT (Figs. 3–5). Generally, overexpression of cPLA2-wt
displayed a similar proﬁle on the enhancement of ER stress. cPLA2-wt
was overexpressed at a level signiﬁcantly greater than the mutant
(Fig. 2), and a portion of the wt enzyme was associated with the
membrane fraction (Fig. 1). Nevertheless, the majority of cPLA2-wt
was in the cytosol, and its effect on enhancing changes in grp94 and
CHOP, compared to its total level of expression, was less robust than
cPLA2-ERmut. While recognizing that overexpression experiments
have to be interpreted with a degree of caution, together, the results
imply that the action of cPLA2 at the ER contributes to induction of ER
stress.
In addition to cPLA2, an association of group VIA calcium-
independent PLA2 (iPLA2-β) and ER stress has been demonstrated
[37–39]. Overexpression of iPLA2-β in insulinoma cells exacerbated
ER stress-associated apoptosis. In addition, there was an association of
apoptosis with an increase in iPLA2-β activity and a perinuclear
accumulation of iPLA2-β activity and protein, consistent with
localization of at least a portion of iPLA2-β at the ER. Overexpression
of iPLA2-β also enhanced accumulation of ceramide (a lipid mediator
of apoptosis), and ampliﬁed induction of grp78, and CHOP, as well as
phosphorylation of PERK in cells incubated with the ER stress inducer,
thapsigargin.
We considered potential mechanisms by which cPLA2 could
potentially enhance ER stress. The effect of cPLA2-ERmut on
enhancement of CHOP expression by tunicamycin was blocked by
the cPLA2-directed inhibitor, AACOCF3 (Fig. 4), implying that the
effect involved cPLA2 enzymatic activity. In contrast to cPLA2-ERmut,
expression of the cPLA2 CaLB domain (which associates, at least in
part, with the membrane of the ER) did not enhance the tunicamycin-
mediated induction of CHOP, indicating that overexpression of a
protein, particularly a protein that can bind to the membrane of the
ER, was not sufﬁcient to facilitate induction of ER stress (Fig. 7). Our
experiments support the view that the action of cPLA2-ERmut
involved oxidative stress. First, the enhancement of CHOP expression
induced by tunicamycin in the presence of cPLA2-ERmut was
attenuated in the presence of NAC or GSH (Fig. 9). Second, the
increase in CHOP expression induced by cPLA2-ERmut and tunicamy-
cin was further enhanced in the presence of BSO (Fig. 9). Third, there
was signiﬁcantly greater superoxide production in COS cells after
transfection of cPLA2-ERmut, compared with control cells (Fig. 10).
The ER contains membrane-bound electron-transport systems that
participate in hydroxylation and desaturation reactions. Microsomal
Fig. 9.Modulation of ER stress byNAC, GSH and BSO. COS cells were transiently transfectedwith cPLA2-ERmut cDNA, as indicated (A, C, D and E), orwere transiently transfectedwith a
control plasmid (vector; B). Tunicamycin (10 µg/ml) was added after 48 h, and the cells were further incubated for 24 h. Some incubations included NAC (20 µM), GSH (20 µM), or
BSO (100 µM), which were added with the tunicamycin. Lysates were immunoblotted with anti-cPLA2 or anti-CHOP antibodies. C: Densitometric quantiﬁcation, *pb0.001 cPLA2-
ERmut vs control (tunicamycin), **pb0.035 cPLA2-ERmut vs cPLA2-ERmut+NAC, +pb0.004 cPLA2-ERmut vs cPLA2-ERmut+GSH, 3 experiments. E: *pb0.02 cPLA2-ERmut
+tunicamycin vs tunicamycin, **pb0.05 cPLA2-ERmut+tunicamycin+BSO vs cPLA2-ERmut+tunicamycin, 4 experiments. F: Exogenous H2O2 does not increase expression of grp94
or CHOP. COS cells were incubated with H2O2 (0.1 mM) or tunicamycin (10 µg/ml), as indicated. After 24 h, lysates were immunoblotted with anti-grp94 or anti-CHOP antibodies.
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protein and lipid modiﬁcation. “Electron leaks” from these enzymatic
systemsmay give rise to ROS [40,41]. It is conceivable that expression ofcPLA2-ERmut increased ROS production by perturbing reactions
involving ER oxidoreductases. Other pathways of ROS production also
deserve consideration. Expression of cPLA2-ERmut and/or protein
Fig. 10. Expression of cPLA2-ERmut increases production of superoxide anion. Superoxide productionwasmonitored by photoemission (RLU). COS cells were transfectedwith vector
(control) or cPLA2-ERmut cDNAs (A and B). In separate experiments, COS cells were transfected with vector (control) or cPLA2-wt cDNAs (B). After 48 h, cells were lysed, luciginin
was added to the lysates, and RLU was monitored for 80 s. A representative tracing of RLU (A) and change in slope values (B) are presented (B: *pb0.0002 ERmut vs control, 13
experiments; the difference between wt and control is not signiﬁcant, 6 experiments). COS cells were untreated (Untr) or were incubated with tunicamycin (Tunic, 10 µg/ml) for
24 h (C). There are no signiﬁcant differences between groups. Expression of cPLA2-ERmut does not affect ER Ca2+ (D). COS cells were transiently transfected with cPLA2-wt and
cPLA2-ERmut cDNAs, as indicated. After loading with fura-2 AM, the cells were placed in Ca2+-free buffer (untreated; U). Then, cells were incubated with ionomycin (Io; 5 µM).
Results are presented as the ratio (R) of excitation at 340 to 380 nm, which correlates with [Ca2+]i. Under these experimental conditions, the increase in R following ionomycin
treatment reﬂects the amount of Ca2+ in the ER. There are no signiﬁcant differences among groups (6 experiments).
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the ER, and uptake of Ca2+ into the mitochondria could disrupt the
electron-transport chain, increasing ROS [20,42]. We could not
detect Ca2+ leak in resting cells that express cPLA2-ERmut, suggest-
ing that such a mechanism is less likely (Fig. 10). Another possibility
is ROS production via the NADPH oxidase, possibly involving release
of AA [32,33], although one study has reported that COS cells may not
express certain components of the NADPH oxidase [43]. The
cyclooxygenase enzymes are associated with the ER, and metabo-
lism of AA via cyclooxygenase could potentially contribute to the
production of oxidative stress, which in turn enhanced ER stress.
Cyclooxygenases have the peculiar property of catalyzing two
different reactions, oxygenation of AA to prostaglandin G2, and the
subsequent conversion of prostaglandin G2 to prostaglandin H2.
Whereas the ﬁrst reaction requires peroxides, prostaglandin H2
synthase activity is accompanied by formation of ROS [44]. Further
studies will be required to achieve a better understanding of the
mechanism of oxidative stress.
Although upregulation of CHOP by cPLA2-ERmut plus tunicamycin
was attenuated by NAC and GSH, CHOP expression was not increased
by exposure of cells to exogenous H2O2 (Fig. 9). These results suggest
that there are qualitative differences between the production of ROS
by cPLA2-ERmut vs addition of exogenous ROS, or that endogenously
and exogenously produced ROS may be qualitatively different, and
may be produced and act in distinct subcellular compartments. An
analogous situation occurred in L929 cells treated with TNFα [45].This agonist induced the UPR in a ROS-dependent manner, while
exogenous H2O2 was not effective.
Incubation of COS cells with tunicamycin did not lead to signiﬁcant
production of superoxide anion (Fig. 10), implying that in COS cells,
accumulation of misfolded proteins in the ER lumenwas not sufﬁcient
to produce detectable levels of ROS even though grp94 and CHOP had
been induced. Distinct results were observed in CHO cells and
hepatocytes [46]; in these cells, both misfolded proteins and ROS
may be required to activate the UPR and apoptosis. In other cell lines,
ROS production did not appear to contribute to activation of the UPR,
although ROS exacerbated UPR-dependent apoptosis [47]. Presently,
it is not known precisely how protein misfolding in the ER may
generate ROS, but several potential mechanisms exist [20]. Misfolded
proteins bind chaperones, such as grp94, which consume ATP that
may stimulate mitochondrial oxidative phosphorylation to produce
ROS as a byproduct. ROS may be produced following disulﬁde bond
formation in the ER during the transfer of electrons from thiol groups
in folding substrates to molecular oxygen. GSH may be consumed
during reduction of improper disulﬁde bonds in misfolded proteins.
ROS could, in turn, exacerbate protein misfolding in the ER lumen by
oxidizing amino acids in folding proteins, or modifying chaperone
and/or ER-associated degradation functions, as a result amplifying the
UPR [46].
Activation of the UPR may be cytoprotective, e.g. induction of
grp94 enhances the chaperoning capacity of the cell [16,17]. Sustained
ER stress may, however, lead to apoptosis, via upregulation or
Fig. 11. Expression of cPLA2-ERmut enhances induction of apoptosis. COS cells were
transiently transfected with control plasmid (Ctrl), cPLA2-wt (WT) or cPLA2-ERmut
(Mut) cDNAs, as indicated. Tunicamycin (10 µg/ml) was added just after the
transfection, and cells were incubated for 72 h. Apoptosis was measured using Hoechst
H33342 staining. A and B: Representative photomicrographs of Hoechst H33342
staining in COS cells transfected with cPLA2-ERmut, treated without (A) and with (B)
tunicamycin. Arrows point to some of the condensed nuclei (apoptotic cells).
C: Quantiﬁcation of apoptosis. *pb0.05 cPLA2-ERmut+tunicamycin vs control/
tunicamycin, 4 experiments.
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some types of ER stress are associated with cytoprotection, whereas
others lead to apoptosis is not well-established [19]. A recent study
showed that after stimulation of cells with low doses of compounds
that induce ER stress, mRNAs for bip and CHOP were induced, but
while the bip mRNA was stable and persisted, the CHOP mRNA was
unstable and decayed [50]. In this context, the UPR was cytoprotec-
tive. After stimulation with the same compounds at high doses, CHOP
mRNA became more stable, and consequently, the UPR may become
proapoptotic. In the present study, treatment of cPLA2-ERmut-
transfected cells with tunicamycin, enhanced CHOP expression, and
in parallel, this induction of CHOP was associated with a signiﬁcant
increase in apoptosis (Fig. 11). Although the exact mechanism by
which CHOP mediates apoptosis is unknown, CHOP activates thetranscription of cell death genes, including Gadd34, Ero1, Bim, Trb3,
and others. Increased expression of ERO1 (an ER oxidase) causes
hyperoxidation of the ER [20,51]. Indeed, overexpression of CHOPwas
shown to deplete cellular GSH and exaggerate production of ROS [48].
It has been demonstrated that CHOP gene deletion reduces oxidative
stress, UPR induction, and apoptosis in hepatocytes [46]. In addition,
antioxidant treatment reduced UPR induction (including CHOP),
oxidative stress, and apoptosis. The ER stress-induced alterations
in gene expression observed after CHOP deletion were similar to
the changes in gene expression caused by antioxidant treatment,
suggesting that antioxidants and CHOP deletion may improve ER
function through a common mechanism. Further studies will be
required to fully elucidate the mechanisms of how ER phospholipid
hydrolysis, oxidative stress and ER stress interact and lead to cell
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